PRESS-NEWS.org - Press Release Distribution
PRESS RELEASES DISTRIBUTION

Scientists solve 40-year mystery of how sodium controls opioid brain signaling

The findings pave way for new therapies for treating pain and mood disorders

2014-01-13
(Press-News.org) Contact information: Mika Ono
mikaono@scripps.edu
858-784-2052
Scripps Research Institute
Scientists solve 40-year mystery of how sodium controls opioid brain signaling The findings pave way for new therapies for treating pain and mood disorders

LA JOLLA, CA—January 12, 2014—Scientists have discovered how the element sodium influences the signaling of a major class of brain cell receptors, known as opioid receptors. The discovery, from The Scripps Research Institute (TSRI) and the University of North Carolina (UNC), suggests new therapeutic approaches to a host of brain-related medical conditions.

"It opens the door to understanding opioid related drugs for treating pain and mood disorders, among others," said lead author Dr. Gustavo Fenalti, a postdoctoral fellow in the laboratory of Professor Raymond C. Stevens of TSRI's Department of Integrative Structural and Computational Biology.

"This discovery has helped us decipher a 40-year-old mystery about sodium's control of opioid receptors," said Stevens, who was senior author of the paper with UNC pharmacologist Professor Bryan Roth. "It is amazing how sodium sits right in the middle of the receptor as a co-factor or allosteric modulator."

The findings appear in an advanced online publication in the journal Nature on January 12, 2014.

A Sharper Image

The researchers revealed the basis for sodium's effect on signaling with a high-resolution 3-D view of an opioid receptor's atomic structure. Opioid receptors are activated by peptide neurotransmitters (endorphins, dynorphins and enkephalins) in the brain. They can also be activated by plant-derived and synthetic drugs that mimic these peptides: among them morphine, codeine, oxycodone and heroin.

Despite these receptors' crucial importance in health and disease, including pain disorders and addictions, scientists have only begun to understand in detail how they work. Opioid receptors are inherently flimsy and fragile when produced in isolation, and thus have been hard to study using X-ray crystallography, the usual structure-mapping method for large proteins.

In recent years, the Stevens laboratory has helped pioneer the structure determination of G protein-coupled receptors. Although the first crystallographic structures of opioid receptors were determined in 2012, these structural models weren't fine-grained enough to solve a lingering mystery, particularly for the human delta opioid receptor.

That mystery concerned the role of sodium. The element is perhaps best known to biologists as one of the key "electrolytes" needed for the basic workings of cells. In the early 1970s, researchers in the laboratory of neuroscientist Solomon Snyder at Johns Hopkins University, who had helped discover opioid receptors, found evidence that sodium ions also act as a kind of switch on opioid receptor signaling. They noted that at concentrations normally found in brain fluid, these ions reduced the ability of opioid peptides and drugs like morphine to interact with opioid receptors.

How sodium could exert this indirect ("allosteric") effect on opioid receptor activity was unclear—and has remained an unsolved puzzle for decades. Now that scientists have discovered the mechanism of sodium's effect, then in principle they can exploit it to develop better opioid-receptor-targeting drugs.

A Switch Controlling Pain, Depression and Mood Disorders

For the new study, the team constructed a novel, fusion-protein-stabilized version of one of the main opioid receptors in the human brain, known as the delta opioid receptor, and managed to form crystals of it for X-ray crystallography. The latter revealed the receptor's 3-D atomic structure to a resolution of 1.8 Angstroms (180 trillionths of a meter)—the sharpest picture yet of an opioid receptor.

"Such a high resolution is really necessary to be able to understand in detail how the receptor works," said Stevens.

The analysis yielded several key details of opioid receptor structure and function, most importantly the details of the "allosteric sodium site," where a sodium ion can slip in and modulate receptor activity.

The team was able to identify the crucial amino acids that hold the sodium ion in place and transmit its signal-modulating effect. "We found that the presence of the sodium ion holds the receptor protein in a shape that gives it a different affinity for its corresponding neurotransmitter peptides," Fenalti said.

With the structural data in hand, the researchers designed new versions of the receptor, in which key sodium-site amino-acids were mutated, to see how this would affect receptor signaling. Co-lead author Research Associate Patrick M. Giguere and colleagues in Roth's Laboratory at UNC, which has long collaborated with the Stevens laboratory, tested these mutant receptors and found that certain amino-acid changes cause radical shifts in the receptor's normal signaling response.

The most interesting shifts involved a little-understood secondary or "alternative" signaling route, known as the beta-arrestin pathway, whose activity can have different effects depending on the type of brain cell involved. Some drugs that normally bind to the delta opioid receptor and have little or no effect on the beta-arrestin pathway turned out to strongly activate this pathway in a few of these mutant receptors.

In practical terms, these findings suggests a number of ways in which new drugs could target these receptors—and not only delta opioid receptors but also the other two "classical" opioid receptors, mu and kappa opioid receptors. "The sodium site architecture and the way it works seems essentially the same for all three of these opioid receptor types," said Fenalti.



INFORMATION:

Other co-authors of the study, "Molecular control of Delta-opioid receptor signaling," were Assistant Professor Vsevolod Katritch, former Staff Scientist Aaron A. Thompson and Associate Professor Vadim Cherezov of TSRI, and Assistant Scientific Director Xi-Ping Huang of the University of North Carolina.

The research was funded in part by the National Institutes of Health (grants P50 GM073197, U54 GM094618, R01 DA017204), the National Cancer Institute (Y1-CO-1020), the National Institute for General Medical Sciences (Y1-GM-1104) and the National Institute of Mental Health Psychoactive Drug Screening Program.



ELSE PRESS RELEASES FROM THIS DATE:

It's all coming back to me now: Researchers find caffeine enhances memory

2014-01-13
It's all coming back to me now: Researchers find caffeine enhances memory For some, it's the tradition of steeping tealeaves to brew the perfect cup of tea. For others, it's the morning shuffle to a coffee maker for a hot jolt of java. Then there are those who ...

Mutation discovery may improve treatment for rare brain tumor type

2014-01-13
Mutation discovery may improve treatment for rare brain tumor type Study findings could lead to targeted therapies for hard-to-treat craniopharyngiomas BOSTON, Jan. 12, 2014 -- Scientists have identified a mutated gene that causes a type of tenacious, ...

Non-coding DNA implicated in type 2 diabetes

2014-01-13
Non-coding DNA implicated in type 2 diabetes Variations in non-coding sections of the genome might be important contributors to type 2 diabetes risk, according to a new study. DNA sequences that don't encode proteins were once dismissed as "junk DNA", ...

Multi-institutional team finds targetable mutation in rare brain tumor

2014-01-13
Multi-institutional team finds targetable mutation in rare brain tumor BRAF mutation associated with other cancers appears to drive papillary craniopharyngiomas A team led by investigators from Massachusetts General Hospital (MGH), Brigham and Women's ...

Designer 'swiss-army-knife' molecule captures RNA in single cells in their natural tissue environment

2014-01-13
Designer 'swiss-army-knife' molecule captures RNA in single cells in their natural tissue environment Findings allow for better understanding of how tissue microenvironment affects gene expression in healthy and diseased cells PHILADELPHIA ...

Ultrasound directed to the human brain can boost sensory performance

2014-01-13
Ultrasound directed to the human brain can boost sensory performance Virginia Tech Carilion Research Institute scientists say ultrasound ranks with leading neuromodulation techniques in achieving spatial resolution Whales, bats, and even praying mantises use ultrasound as a sensory ...

Tweaking MRI to track creatine may spot heart problems earlier, Penn Medicine study suggests

2014-01-13
Tweaking MRI to track creatine may spot heart problems earlier, Penn Medicine study suggests Measuring creatine levels with MRI has benefits over contrast-enhanced MRI and MRS PHILADELPHIA— A new MRI method to map creatine at higher ...

Study: At-home test can spot early Alzheimer's

2014-01-13
Study: At-home test can spot early Alzheimer's Finding symptoms early is crucial to treatment, at-home paper test can help COLUMBUS, Ohio – The Self-Administered Gerocognitive Examination (SAGE test), which takes less than 15 minutes ...

School drug tests don't work, but 'positive climate' might

2014-01-13
School drug tests don't work, but 'positive climate' might PISCATAWAY, NJ – School drug testing does not deter teenagers from smoking marijuana, but creating a "positive school climate" just might, according to research reported in the ...

Brief mental training sessions have long-lasting benefits for seniors' cognition and everyday function

2014-01-13
Brief mental training sessions have long-lasting benefits for seniors' cognition and everyday function Older adults who received as few as 10 sessions of mental (cognitive) training showed improvements in reasoning ability and speed-of-processing when compared with untrained ...

LAST 30 PRESS RELEASES:

Cercus electric stimulation enables cockroach with trajectory control and spatial cognition training

Day-long conference addresses difficult to diagnose lung disease

First-ever cardiogenic shock academy features simulation lab

Thirty-year mystery of dissonance in the “ringing” of black holes explained

Less intensive works best for agricultural soil

Arctic rivers project receives “national champion” designation from frontiers foundation

Computational biology paves the way for new ALS tests

Study offers new hope for babies born with opioid withdrawal syndrome

UT, Volkswagen Group of America celebrate research partnership

New Medicare program could dramatically improve affordability for cancer drugs – if patients enroll

Are ‘zombie’ skin cells harmful or helpful? The answer may be in their shapes

University of Cincinnati Cancer Center presents research at AACR 2025

Head and neck, breast, lung and survivorship studies headline Dana-Farber research at AACR Annual Meeting 2025

AACR: Researchers share promising results from MD Anderson clinical trials

New research explains why our waistlines expand in middle age

Advancements in muon detection: Taishan Antineutrino Observatory's innovative top veto tracker

Chips off the old block

Microvascular decompression combined with nerve combing for atypical trigeminal neuralgia

Cutting the complexity from digital carpentry

Lung immune cell type “quietly” controls inflammation in COVID-19

Fiscal impact of expanded Medicare coverage for GLP-1 receptor agonists to treat obesity

State and sociodemographic trends in US cigarette smoking with future projections

Young adults drive historic decline in smoking

NFCR congratulates Dr. Robert C. Bast, Jr. on receiving the AACR-Daniel D. Von Hoff Award for Outstanding Contributions to Education and Training in Cancer Research

Chimpanzee stem cells offer new insights into early embryonic development

This injected protein-like polymer helps tissues heal after a heart attack

FlexTech inaugural issue launches, pioneering interdisciplinary innovation in flexible technology

In Down syndrome mice, 40Hz light and sound improve cognition, neurogenesis, connectivity

Methyl eugenol: potential to inhibit oxidative stress, address related diseases, and its toxicological effects

A vascularized multilayer chip reveals shear stress-induced angiogenesis in diverse fluid conditions

[Press-News.org] Scientists solve 40-year mystery of how sodium controls opioid brain signaling
The findings pave way for new therapies for treating pain and mood disorders